AZN vs CTNM · P/E 28, $288.38B cap vs $429.6M cap
AstraZeneca PLC (AZN) versus Contineum Therapeutics, Inc. Class A Common Stock (CTNM) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CTNM currently screens at market cap $429.6M.
Not investment advice. Open the AZN and CTNM stock pages for the full models.
Not investment advice.